Trial Profile
Action of the Vidaza on the Atrial Fibrillation
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Dec 2021
Price :
$35
*
At a glance
- Drugs Azacitidine (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- Acronyms AVIFA
- 15 Oct 2019 Planned End Date changed from 1 Oct 2020 to 20 Dec 2021.
- 15 Oct 2019 Planned primary completion date changed from 1 Oct 2020 to 20 Dec 2021.
- 15 Oct 2019 Status changed from not yet recruiting to recruiting.